Search is Powered by Google
Breast Cancer News

Side Effects Could Cause Women To Stop Taking Drugs Aimed At Preventing Breast Cancer Recurrence, Studies Say

Main Category: Breast Cancer
Also Included In: Compliance;  Women's Health / Gynecology
Article Date: 12 Sep 2007 - 8:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 and a half stars

4.5 (4 votes)

Health Professional:4 stars

4 (1 votes)

Article Opinions: 0 posts

Some women taking the drugs tamoxifen and aromatase inhibitors, which block the production of estrogen, to prevent breast cancer recurrence are ending their therapy prematurely because of side effects, according to two studies presented Thursday at the 2007 Breast Cancer Symposium in San Francisco, Reuters reports.

For one study, Alastair Thompson of the University of Dundee in Scotland and colleagues examined the records of 2,080 women treated for breast cancer between 1993 and 2002. The women in the study took tamoxifen for an average of just under 2.5 years to help prevent breast cancer recurrence. Tamoxifen is shown to be most effective if taken for five years, Reuters reports. According to the study, 10% of the women failed to fill 30% or more of their tamoxifen prescriptions. These women were 16% more likely to die during the study period than women who remained on their tamoxifen regimens as directed, the study found. "It could well be a question of side effects," Thompson said, adding, "I think most women who take tamoxifen know that it does have very substantial and life-affecting side effects, even if just hot flashes, which can make life a misery."

In the second study, Lynn Henry of the University of Michigan Comprehensive Cancer Center enrolled 100 women in a trial comparing two different aromatase inhibitors. The study showed that 13% of women taking an aromatase inhibitor requested to be taken off the drug because of muscle aches. Twenty-three percent of the 100 women dropped out of the trial, Henry said. "The vast majority of patients are switching to something else," she said, adding, "They understand that they still need to have their breast cancer treated" (Fox, Reuters, 9/6).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

Breast Cancer Treatment: Get Involved image Breast Cancer Treatment: Get Involved

Today, breast cancer patients may be treated by a multidisciplinary team of specialists, consisting of nurses, oncologists, surgeons, social workers, nutritionists and genetic counselors. However, patients, too, have a critical role in their treatment...

View more videos...